|
1.
|
原著(症例報告除く)
|
Thiazoline-related innate fear stimuli orchestratehypothermia and anti-hypoxia via sensory TRPA1activation 2021/04
|
|
2.
|
原著(症例報告除く)
|
Differential regulation of CYP46A1 in ischemic core and peri-infarct regions of male mouse brain after permanent middle cerebral artery occlusion. 2026/11
|
|
3.
|
症例報告
|
Primary Cerebral Pleomorphic-Myxoid Sarcoma With Many Hyaline Globules. 2026/10
|
|
4.
|
その他
|
がん微小環境を標的とした新たながん治療シーズ探索のための研究基盤の構築 2026/09
|
|
5.
|
原著(症例報告除く)
|
Machine Learning Reveals the Contribution of Rare Genetic Variants and Enhances Risk Prediction for Coronary Artery Disease in the Japanese Population. 2026/08
|
|
6.
|
原著(症例報告除く)
|
Association Between Repeated Prophylactic Antimicrobial Eye Drop Use and Reduced Antimicrobial Susceptibility in Conjunctival and Nasal Commensal Bacteria. 2026/07
|
|
7.
|
症例報告
|
Identification of tubulin gene variants in patients with dandy-walker malformation: expanding the spectrum of tubulinopathies. 2026/06
|
|
8.
|
原著(症例報告除く)
|
Raman signatures of Cnm-positive Streptococcus mutans: III, clinical validation. 2026/05
|
|
9.
|
原著(症例報告除く)
|
Predicting mild familial exudative vitreoretinopathy with autosomal dominant inheritance using deep learning. 2026/04
|
|
10.
|
原著(症例報告除く)
|
Raman signatures of Cnm-positive Streptococcus mutans: I, the molecular origin of cerebral microbleeds. 2026/04
|
|
11.
|
原著(症例報告除く)
|
Raman signatures of Cnm-positive Streptococcus mutans: II, screening the virulence of clinical isolates. 2026/04
|
|
12.
|
原著(症例報告除く)
|
Whole-genome sequencing of 3135 individuals representing the genetic diversity of the Japanese population. 2026/04
|
|
13.
|
その他
|
川崎病の罹患感受性因子としての腸内細菌叢の乱れ 2025/12
|
|
14.
|
原著(症例報告除く)
|
Anamorelin in Cancer Cachexia: Gut Microbiota Effects and CONUT Score as a Predictor of Response. 2025/11
|
|
15.
|
原著(症例報告除く)
|
HMGA2 links morphological evolution and microenvironment dynamics to systemic therapy response in clear cell renal cell carcinoma. 2025/11
|
|
16.
|
症例報告
|
Elderly-onset iatrogenic cerebral amyloid angiopathy presenting with lobar and deep haemorrhages. 2025/10
|
|
17.
|
原著(症例報告除く)
|
Whole-genome sequencing reveals rare and structural variants contributing to psoriasis and identifies CERCAM as a risk gene. 2025/10
|
|
18.
|
原著(症例報告除く)
|
The Arf pathway is required for resolving endoplasmic reticulum stress during T-cell activation 2025/09
|
|
19.
|
原著(症例報告除く)
|
Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Cancer. 2025/08
|
|
20.
|
原著(症例報告除く)
|
Molecular Insights into the Superiority of Platelet Lysate over FBS for hASC Expansion and Wound Healing 2025/07
|
|
21.
|
原著(症例報告除く)
|
Blood DNA virome associates with autoimmune diseases and COVID-19 2025/01
|
|
22.
|
原著(症例報告除く)
|
Nerve Enlargement in Patients with INF2 Variants Causing Peripheral Neuropathy and Focal Segmental Glomerulosclerosis 2025/01
|
|
23.
|
原著(症例報告除く)
|
Raman signatures of type A and B influenza viruses: molecular origin of the " catch and kill" inactivation mechanism mediated by micrometric silicon nitride powder 2025/01
|
|
24.
|
症例報告
|
VANGL2とGRHL2のヘテロミスセンス変異を認めた脊髄脂肪腫の1例 2024/04
|
|
25.
|
症例報告
|
二分脊椎症における遺伝子変異と形態異常 2024/04
|
|
26.
|
原著(症例報告除く)
|
Familial Exudative Vitreoretinopathy With and Without Pathogenic Variants of Norrin/β-Catenin Signaling Genes 2024/03
|
|
27.
|
原著(症例報告除く)
|
OLIG2 translocates to chromosomes during mitosis via a temperature downshift: a novel neural cold response of mitotic bookmarking 2024/01
|
|
28.
|
原著(症例報告除く)
|
Raman Fingerprints of SARS-CoV-2 Omicron Subvariants: Molecular Roots of Virological Characteristics and Evolutionary Directions 2023/11
|
|
29.
|
原著(症例報告除く)
|
Dysbiosis of the gut microbiota as a susceptibility factor for Kawasaki disease 2023/10
|
|
30.
|
原著(症例報告除く)
|
Raman Multi-Omic Snapshot and Statistical Validation of Structural Differences between Herpes Simplex Type I and Epstein-Barr Viruses 2023/10
|
|
31.
|
原著(症例報告除く)
|
Relationship between circulating mitochondrial DNA and microRNA in patients with major depression 2023/10
|
|
32.
|
症例報告
|
Adenoid ameloblastoma with BRAF p.V600E mutation revealing ameloblastomatous origin: a first case report 2023/09
|
|
33.
|
原著(症例報告除く)
|
Changes in Multiple microRNA Levels with Antidepressant Treatment Are Associated with Remission and Interact with Key Pathways: A Comprehensive microRNA Analysis 2023/07
|
|
34.
|
原著(症例報告除く)
|
Characterization of cytoskeletal and structural effects of INF2 variants causing glomerulopathy and neuropathy 2023/07
|
|
35.
|
原著(症例報告除く)
|
Rap1 organizes lymphocyte front-back polarity via RhoA signaling and talin1 2023/07
|
|
36.
|
原著(症例報告除く)
|
OLIG2 is an in vivo bookmarking transcription factor in the developing neural tube in mouse 2023/05
|
|
37.
|
症例報告
|
ゲノム解析にて特定したtubulin遺伝子の変異を有する難治性脳形成障害 2023/05
|
|
38.
|
原著(症例報告除く)
|
Ago2 and a miRNA reduce Topoisomerase 1 for enhancing DNA cleavage in antibody diversification by activation-induced cytidine deaminase 2023/04
|
|
39.
|
症例報告
|
全ゲノム解析を用いた難治性脳形成障害の遺伝子異常検索 2023/04
|
|
40.
|
原著(症例報告除く)
|
Areas of Crush Nuclear Streaming Should Be Included as Tumor Content in the Era of Molecular Diagnostics 2023/03
|
|
41.
|
症例報告
|
新規subtypeとみなされるBRAF mutationが検出されたadenoid ameloblastomaの一例 2023/03
|
|
42.
|
原著(症例報告除く)
|
Deep learning-based predictions of clear and eosinophilic phenotypes in clear cell renal cell carcinoma 2023/01
|
|
43.
|
その他
|
Activation-induced cytidine deaminase(AID)による免疫記憶形成に必要なAgo2-miRNA依存的なtopoisomerase1(Top1)の調節機構 2023
|
|
44.
|
その他
|
Ago2とmiRNAはAID依存性の抗体遺伝子組換えにおけるDNA切断を促進するためにDNAトポイソメラーゼ1を減少させる 2023
|
|
45.
|
その他
|
本邦のうつ病患者における疾患発症,薬物治療反応性に関するゲノムワイド関連解析(GWAS) 2023
|
|
46.
|
原著(症例報告除く)
|
Accelerated Angiogenesis of Human Umbilical Vein Endothelial Cells Under Negative Pressure Was Associated With the Regulation of Gene Expression Involved in the Proliferation and Migration 2022/12
|
|
47.
|
原著(症例報告除く)
|
Multidimensional analyses of the pathomechanism caused by the non-catalytic GNE variant, c.620A>T, in patients with GNE myopathy 2022/12
|
|
48.
|
症例報告
|
Successful pregnancy and delivery in a young-onset hypertrophic cardiomyopathy patient with a novel doublet-base substitution in the MYH7 gene 2022/10
|
|
49.
|
原著(症例報告除く)
|
Development and validation of a vascularity-based architectural classification for clear cell renal cell carcinoma: correlation with conventional pathological prognostic factors, gene expression patterns, and clinical outcomes 2022/06
|
|
50.
|
その他
|
Correction to: Development and validation of a vascularity-based architectural classification for clear cell renal cell carcinoma: correlation with conventional pathological prognostic factors, gene expression patterns, and clinical outcomes 2022/05
|
|
51.
|
原著(症例報告除く)
|
Multiple Pre-Treatment miRNAs Levels in Untreated Major Depressive Disorder Patients Predict Early Response to Antidepressants and Interact with Key Pathways 2022/03
|
|
52.
|
原著(症例報告除く)
|
PBRM1 Immunohistochemical Expression Profile Correlates with Histomorphological Features and Endothelial Expression of Tumor Vasculature for Clear Cell Renal Cell Carcinoma 2022/02
|
|
53.
|
原著(症例報告除く)
|
Histologic-Based Tumor-Associated Immune Cells Status in Clear Cell Renal Cell Carcinoma Correlates with Gene Signatures Related to Cancer Immunity and Clinical Outcomes 2022/01
|
|
54.
|
その他
|
【ゲノム医療におけるデータベース-使い方とコツ】一般集団・多因子疾患関連バリアントのデータベース Human Genetic Variation Database(HGVD) 2022/01
|
|
55.
|
原著(症例報告除く)
|
Eosinophilic features in clear cell renal cell carcinoma correlate with outcomes of immune checkpoint and angiogenesis blockade 2021/09
|
|
56.
|
原著(症例報告除く)
|
Genome-wide association study of individual differences of human lymphocyte profiles using large-scale cytometry data 2021/06
|
|
57.
|
原著(症例報告除く)
|
Population dynamics in the Japanese Archipelago since the Pleistocene revealed by the complete mitochondrial genome sequences 2021/06
|
|
58.
|
原著(症例報告除く)
|
Positive renal familial history in IgA nephropathy is associated with worse renal outcomes: a single-center longitudinal study 2021/06
|
|
59.
|
症例報告
|
Combined Single Nucleotide Variants of ORAI1 and BLK in a Child with Refractory Kawasaki Disease 2021/05
|
|
60.
|
原著(症例報告除く)
|
Genotype-Phenotype Correlations in RP1-Associated Retinal Dystrophies: A Multi-Center Cohort Study in JAPAN 2021/05
|
|
61.
|
原著(症例報告除く)
|
Digenic mutations in ALDH2 and ADH5 impair formaldehyde clearance and cause a multisystem disorder, AMeD syndrome. 2020/12
|
|
62.
|
原著(症例報告除く)
|
EYS is a major gene involved in retinitis pigmentosa in Japan: genetic landscapes revealed by stepwise genetic screening 2020/11
|
|
63.
|
原著(症例報告除く)
|
Population-specific and trans-ancestry genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease. 2020/11
|
|
64.
|
原著(症例報告除く)
|
Association of ALPL variants with serum alkaline phosphatase and bone traits in the general Japanese population: The Nagahama Study. 2020/03
|
|
65.
|
原著(症例報告除く)
|
Legacy Data Confounds Genomics Studies 2020/01
|
|
66.
|
原著(症例報告除く)
|
IgG4-related disease in the Japanese population: a genome-wide association study. 2019/09
|
|
67.
|
原著(症例報告除く)
|
Genetic basis for plasma amino acid concentrations based on absolute quantification: a genome-wide association study in the Japanese population. 2019/04
|
|
68.
|
原著(症例報告除く)
|
National platform for Rare Diseases Data Registry of Japan 2019/01
|
|
69.
|
原著(症例報告除く)
|
Accurate diagnosis of mismatch repair deficiency in colorectal cancer using high-quality DNA samples from cultured stem cells. 2018/12
|
|
70.
|
原著(症例報告除く)
|
A mutation in transcription factor MAFB causes Focal Segmental Glomerulosclerosis with Duane Retraction Syndrome 2018/08
|
|
71.
|
原著(症例報告除く)
|
Regional genetic differences among Japanese populations and performance of genotype imputation using whole-genome reference panel of the Tohoku Medical Megabank Project. 2018/07
|
|
72.
|
原著(症例報告除く)
|
Risk allele of FZD4 gene for familial exudative vitreoretinopathy 2018/06
|
|
73.
|
原著(症例報告除く)
|
Expansions of intronic TTTCA and TTTTA repeats in benign adult familial myoclonic epilepsy. 2018/04
|
|
5件表示
|
|
全件表示(73件)
|
